Cite

HARVARD Citation

    Fong, W. et al. (2021). Real‐world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes. Clinical & experimental allergy. 51 (8), pp. 1019-1032. [Online]. 
  
Back to record